Prialt Injection, Solution
NDC Package 68118-723-10
Package Information
Prialt (ziconotide acetate) injection is a medication a non-opioid pain reliever that is used to treat ongoing pain when other treatments or medications cannot control your pain. This formulation utilizes a injection, solution delivery system. Marketed by Esteve Pharmaceuticals, S.a., this product is identified by NDC 68118-723 and is authorized under FDA application NDA021060.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68118 - Esteve Pharmaceuticals, S.a.
- 68118-723 - Prialt
- 68118-723-10 - 1 VIAL, GLASS in 1 CARTON / 20 mL in 1 VIAL, GLASS
- 68118-723 - Prialt
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68118-723-10 identifies a specific commercial package of 1 vial, glass in 1 carton / 20 ml in 1 vial, glass of Prialt, a human prescription drug labeled by Esteve Pharmaceuticals, S.a.. This injection, solution is formulated for intrathecal use and contains ziconotide acetate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Esteve Pharmaceuticals, S.a. on October 15, 2018. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is a non-opioid pain reliever that is used to treat ongoing pain when other treatments or medications cannot control your pain. Ziconotide works by blocking the nerves in the spinal cord that send pain signals. It decreases ongoing pain caused by cancer, AIDS, failed back surgery, multiple sclerosis, neuropathy, and other causes.
How is this Esteve Pharmaceuticals, S.a. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68118072310. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.